Acute Porphyria Drug Database

M01AC06 - Meloxicam
Propably not porphyrinogenic
PNP

Rationale
Substrate for CYP 2C9 and 3A4. One list consider it probably safe.
Chemical description
Tabl, supp, 7-15 mg/d. Analgetic, antipyretic och anti-inflammatory inhibitor of prostaglandin synthesis used in osteoarthrosis. Oxicam derivative, extensively metabolized by hydroxylation by CYP 2C9 (major reaction) and 3A4 (minor reaction). Inhibitor of CYP 2C9. South African list: use with care
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes M01A / M01AC or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙